GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Prostate | ON | Recruiting
MIDAS-Prostate
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer
Dr. Srinivas Raman
Start Date: November 1, 2022

NCT #: NCT05328505

SPONSOR: University Health Network, Toronto

INFOhttps://www.clinicaltrials.gov/ct2/show/NCT05328505

CONTACT: 416-946-2320 

Prostate | ON | Recruiting
MOB-RT
Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer (MOB-RT)
Dr. Rachel Glicksman
Start Date: July 18, 2022

NCT #: NCT05313815

SPONSOR: University Health Network, Toronto

INFO: https://clinicaltrials.gov/ct2/show/NCT05313815

CONTACT:  416-946-4483

Bladder | ON | Recruiting
D9450C00001
A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours
AstraZeneca
Start Date: July 7, 2022

NCT #: NCT05397171

SPONSOR: AstraZeneca

INFOhttps://clinicaltrials.gov/ct2/show/NCT05397171?recrs=abf&cond=Urothelial+Carcinoma&cntry=CA&draw=2&rank=15

CONTACT:  1-877-240-9479

OTHER CANADIAN CENTRES:

1. The Ottawa Hospital

2. Mount Sinai Hospital (Toronto)

Renal | ON | Recruiting
MOHCCN-O
Marathon of Hope Cancer Centres Network Study for Ontario
University Health Network. Collaboration with PMH, OICR and Terry Fox Research Institute
Start Date: June 13, 2022

NCT #: NCT05403177

SPONSOR:  University Health Network

INFOhttps://clinicaltrials.gov/ct2/show/NCT05403177?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=17

CONTACT: 

Sophie Cooke, MSc: 416-946-4501 x 3486

OTHER CANADIAN CENTRES:

Princess Margaret Cancer Centre (Toronto)               

Bladder | ON | Recruiting, by invitation only
ROSY-D
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab (ROSY-D)
Start Date: April 19, 2022

NCT #: NCT05303532

SPONSOR: AstraZeneca

INFO:  https://clinicaltrials.gov/ct2/show/NCT05303532?recrs=abf&cond=Urothelial+Carcinoma&cntry=CA&draw=2&rank=5

CONTACT: Southlake Regional Health Centre (Newmarket): 905-895-4521 (Canadian Site)

OTHER CANADIAN CENTRES:

1. Southlake Regional Health Centre (Newmarket): 905-895-4521

 

Prostate | QC | Recruiting
PROSTEP-002
Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.
Dr. Frédéric Pouliot
Start Date: March 22, 2022

NCT #: NCT04655365

SPONSOR: CHU de Quebec-Universite Laval in collaboration with Astellas

INFOhttps://clinicaltrials.gov/ct2/show/NCT04655365

CONTACT:  418 525-4444 ext 20417

Renal | ON | Recruiting
2021-004968-95
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
GlaxoSmithKline
Start Date: March 22, 2022

NCT #: 2021-004968-95

SPONSOR: GlaxoSmithKline

INFOhttps://clinicaltrials.gov/ct2/show/NCT05277051?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=31

CONTACT: GSKClinicalSupportHD@gsk.com 

OTHER CANADIAN CENTRES:

Princess Margaret Cancer Centre (Toronto)

 

Prostate | ON | Recruiting
ROADSTER
Radioligand for local radiorecurrent prostate cancer
Dr. Glen Bauman
Start Date: March 17, 2022

NCT #: NCT05230251

SPONSOR: London Health Sciences Foundation

INFOhttps://clinicaltrials.gov/ct2/show/NCT05230251

CONTACT:  519-685-8500

Prostate | AB | Recruiting
HREBA.CC-21-0073
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients
Dr. Alexander Tamm & Dr. Adam Kinnaird
Start Date: February 10, 2022

NCT #: NCT05141760

SPONSOR: University of Alberta in collaboration with the Canadian Urological Association Scholarship Foundation.

INFO: https://clinicaltrials.gov/ct2/show/NCT05141760

CONTACT:  780-407-5800 ext 321

Renal | AB | Recruiting
SMART
Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry (SMART)
Dr. Adam Kinnaird & Dr. Nicholas Dean
Start Date: January 27, 2022

NCT #: NCT05210933

SPONSOR: University of Alberta

INFOhttps://clinicaltrials.gov/ct2/show/NCT05210933?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=3

CONTACT:

780-951-2326

780-690-6285

OTHER CANADIAN CENTRES: Calgary & Edmonton